EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties

Romain Regnault iD, Frédérique Klupsch, Hassiba El-Bouazzati, Romain Magnez iD, Raphaël Le Biannic, Natascha Leleu-Chavain iD, Hania Ahouari, Hervé Vezin iD, Régis Millet, Jean-François Goossens iD, Xavier Thuru iD, Christian Bailly iD

Molecules · 15.04.2023 · 28 (8) · 3491

DOI: 10.3390/molecules28083491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 15.04.2023. Verfasst von Romain Regnault und 11 weiteren Autor:innen. Beteiligte Einrichtung: ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU Lille, University Lille, F-59000 Lille, France. Hauptthemen laut MEDLINE: Antioxidants, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Contrat de Plan Etat Région CPER Cancer 2015–2020, SATT Nord and Inserm-Transfert, Start-AIRR from the Région Hauts-de-France/BPI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orally-active anticancer small molecules targeting the PD-1/PD-L1 immune checkpoint are actively searched. Phenyl-pyrazolone derivatives with a high affinity for PD-L1 have been designed and characterized. In addition, the phenyl-pyrazolone unit acts as a scavenger of oxygen free radicals, providing antioxidant effects. The mechanism is known for the drug edaravone (1) which is also an aldehyde-reactive molecule. The present study reports the synthesis and functional characterization of new molecules (2–5) with an improved anti-PD-L1 activity. The leading fluorinated molecule 5 emerges as a potent checkpoint inhibitor, avidly binding to PD-L1, inducing its dimerization, blocking PD-1/PD-L1 signaling mediated by phosphatase SHP-2 and reactivating the proliferation of CTLL-2 cells in the presence of PD-L1. In parallel, the compound maintains a significant antioxidant activity, characterized using electron paramagnetic resonance (EPR)-based free radical scavenging assays with the probes DPPH and DMPO. The aldehyde reactivity of the molecules was investigated using 4-hydroxynonenal (4-HNE), which is a major lipid peroxidation product. The formation of drug-HNE adducts, monitored by high resolution mass spectrometry (HRMS), was clearly identified and compared for each compound. The study leads to the selection of compound 5 and the dichlorophenyl-pyrazolone unit as a scaffold for the design of small molecule PD-L1 inhibitors endowed with antioxidant properties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsProgrammed Cell Death 1 ReceptorDimerizationSignal TransductionAldehydes

Stichwörter der Autor:innen

PD-L1 bindingaldehyde reactivityantioxidantcancerimmune checkpointpyrazolone

Substanzen

AntioxidantsProgrammed Cell Death 1 ReceptorAldehydes

Autor:innen und Institutionen

  • ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU Lille, University Lille, F-59000 Lille, France.
  • U1286-INFINITE-Institute for Translational Research in Inflammation, ICPAL, Inserm, University Lille, F-59000 Lille, France.
  • UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, Inserm, CNRS, CHU Lille, University Lille, F-59000 Lille, France.
  • LASIRE Laboratoire Avancé de Spectroscopie pour les Intéractions la Réactivité et l'Environnement, F-59655 Villeneuve d'Ascq, France.
  • FR 2638-IMEC-Institut Michel-Eugène Chevreul, University Lille, F-59655 Lille, France.
  • Oncowitan, Scientific Consulting Office, Wasquehal, F-59290 Lille, France.

ORCID-Profile: Romain Regnault, Romain Magnez, Natascha Leleu-Chavain, Hervé Vezin, Jean-François Goossens, Xavier Thuru, Christian Bailly

Förderung

  • Contrat de Plan Etat Région CPER Cancer 2015–2020
  • SATT Nord and Inserm-Transfert
  • Start-AIRR from the Région Hauts-de-France/BPI
  • public utility foundation Institut pour la Recherche sur le Cancer de Lille (IRCL)

Zitieren

APA

Regnault, R., Klupsch, F., El-Bouazzati, H., Magnez, R., Le Biannic, R., Leleu-Chavain, N., Ahouari, H., Vezin, H., Millet, R., Goossens, J. F., Thuru, X., & Bailly, C. (2023). Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties. Molecules, 28(8), 3491. https://doi.org/10.3390/molecules28083491

Vancouver

Regnault R, Klupsch F, El-Bouazzati H, Magnez R, Le Biannic R, Leleu-Chavain N, et al. Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties. Molecules. 2023;28(8):3491. doi:10.3390/molecules28083491

BibTeX
@article{Regnault2023,
  author = {Regnault, Romain and Klupsch, Frédérique and El-Bouazzati, Hassiba and Magnez, Romain and Le Biannic, Raphaël and Leleu-Chavain, Natascha and Ahouari, Hania and Vezin, Hervé and Millet, Régis and Goossens, Jean-François and Thuru, Xavier and Bailly, Christian},
  title = {Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {8},
  pages = {3491},
  doi = {10.3390/molecules28083491}
}
Kostenlos starten →